| Dr Joshua Edward Everts, DDS, MD | |
|
420 1st St N, Alabaster, AL 35007-8707 | |
| (205) 208-0167 | |
| Not Available |
| Full Name | Dr Joshua Edward Everts |
|---|---|
| Gender | Male |
| Speciality | Oral Surgery |
| Experience | 12 Years |
| Location | 420 1st St N, Alabaster, Alabama |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427266345 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emory Decatur Hospital | Decatur, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shelby Oral Facial Surgery, P.c. | 1456516624 | 3 |
News Archive
Researchers at the University of Cincinnati have found that the race and sex of study personnel can influence a patient's decision on whether or not to participate in clinical research.
Allegro Diagnostics today announced that results from its AEGIS (Airway Epithelium Gene Expression In the Diagnosis of Lung Cancer) clinical trials, to determine the accuracy of the BronchoGen genomic test, have been accepted for an oral presentation during the late-breaking abstract session at CHEST 2012 on Tuesday, October 23, 2012 at 4:30 p.m. The abstract will also be published in a supplement of the October 2012 issue of CHEST.
Douglas A. Mitchell, IGB faculty member in the Mining Microbial Genomes for Novel Antibiotics research theme and assistant professor in the Department of Chemistry, is a recipient of the 2011 National Institutes of Health Director's New Innovator Award. The award recognizes bold ideas from some of the nation's most promising new scientists.
The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.
› Verified 8 days ago
| Entity Name | Shelby Oral Facial Surgery, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366701450 PECOS PAC ID: 1456516624 Enrollment ID: O20120713000445 |
News Archive
Researchers at the University of Cincinnati have found that the race and sex of study personnel can influence a patient's decision on whether or not to participate in clinical research.
Allegro Diagnostics today announced that results from its AEGIS (Airway Epithelium Gene Expression In the Diagnosis of Lung Cancer) clinical trials, to determine the accuracy of the BronchoGen genomic test, have been accepted for an oral presentation during the late-breaking abstract session at CHEST 2012 on Tuesday, October 23, 2012 at 4:30 p.m. The abstract will also be published in a supplement of the October 2012 issue of CHEST.
Douglas A. Mitchell, IGB faculty member in the Mining Microbial Genomes for Novel Antibiotics research theme and assistant professor in the Department of Chemistry, is a recipient of the 2011 National Institutes of Health Director's New Innovator Award. The award recognizes bold ideas from some of the nation's most promising new scientists.
The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua Edward Everts, DDS, MD 420 1st St N, Alabaster, AL 35007-8707 Ph: (205) 208-0167 | Dr Joshua Edward Everts, DDS, MD 420 1st St N, Alabaster, AL 35007-8707 Ph: (205) 208-0167 |
News Archive
Researchers at the University of Cincinnati have found that the race and sex of study personnel can influence a patient's decision on whether or not to participate in clinical research.
Allegro Diagnostics today announced that results from its AEGIS (Airway Epithelium Gene Expression In the Diagnosis of Lung Cancer) clinical trials, to determine the accuracy of the BronchoGen genomic test, have been accepted for an oral presentation during the late-breaking abstract session at CHEST 2012 on Tuesday, October 23, 2012 at 4:30 p.m. The abstract will also be published in a supplement of the October 2012 issue of CHEST.
Douglas A. Mitchell, IGB faculty member in the Mining Microbial Genomes for Novel Antibiotics research theme and assistant professor in the Department of Chemistry, is a recipient of the 2011 National Institutes of Health Director's New Innovator Award. The award recognizes bold ideas from some of the nation's most promising new scientists.
The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.
› Verified 8 days ago